Cargando…
Safety Interval From Increased Viscosity After COVID-19 Vaccination Among Persons With Cerebrovascular Problems
Autores principales: | Mungmunpuntipantip, Rujittika, Wiwanitkit, Viroj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580489/ https://www.ncbi.nlm.nih.gov/pubmed/34498516 http://dx.doi.org/10.1177/10760296211039015 |
Ejemplares similares
-
Diabetic ketoacidosis, COVID-19 and blood viscosity
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021) -
Blood Viscosity at the First Clinical Presentation in Fatal and Non-Fatal
COVID-19: An Observation
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021) -
Thyrotoxicosis after COVID-19 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021) -
Acute venous thromboembolism after COVID-19 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022) -
Pituitary apoplexy after COVID-19 vaccination: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)